日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

The significance of molecular heterogeneity in breast cancer batch correction and dataset integration

分子异质性在乳腺癌批次校正和数据集整合中的意义

Moir, Nicholas; Pearce, Dominic A; Langdon, Simon P; Simpson, T Ian

Emerging role of nuclear factor erythroid 2-related factor 2 in the mechanism of action and resistance to anticancer therapies

核因子E2相关因子2在抗癌疗法的作用机制和耐药性中发挥着越来越重要的作用

Paramasivan, Poornima; Kankia, Ibrahim H; Langdon, Simon P; Deeni, Yusuf Y

Human epidermal growth factor receptor targeted inhibitors for the treatment of ovarian cancer

用于治疗卵巢癌的人表皮生长因子受体靶向抑制剂

Bonello, Maria; Sims, Andrew Harvey; Langdon, Simon Peter

Predictive markers of endocrine response in breast cancer

乳腺癌内分泌反应的预测标志物

Mosly, Duniya; Turnbull, Arran; Sims, Andrew; Ward, Carol; Langdon, Simon

Increased STAT1 signaling in endocrine-resistant breast cancer

内分泌耐药性乳腺癌中 STAT1 信号传导增强

Huang, Rui; Faratian, Dana; Sims, Andrew H; Wilson, Danielle; Thomas, Jeremy S; Harrison, David J; Langdon, Simon P

Critical research gaps and translational priorities for the successful prevention and treatment of breast cancer

乳腺癌成功预防和治疗的关键研究空白和转化重点

Eccles, Suzanne A; Aboagye, Eric O; Ali, Simak; Anderson, Annie S; Armes, Jo; Berditchevski, Fedor; Blaydes, Jeremy P; Brennan, Keith; Brown, Nicola J; Bryant, Helen E; Bundred, Nigel J; Burchell, Joy M; Campbell, Anna M; Carroll, Jason S; Clarke, Robert B; Coles, Charlotte E; Cook, Gary J R; Cox, Angela; Curtin, Nicola J; Dekker, Lodewijk V; Silva, Isabel dos Santos; Duffy, Stephen W; Easton, Douglas F; Eccles, Diana M; Edwards, Dylan R; Edwards, Joanne; Evans, D; Fenlon, Deborah F; Flanagan, James M; Foster, Claire; Gallagher, William M; Garcia-Closas, Montserrat; Gee, Julia M W; Gescher, Andy J; Goh, Vicky; Groves, Ashley M; Harvey, Amanda J; Harvie, Michelle; Hennessy, Bryan T; Hiscox, Stephen; Holen, Ingunn; Howell, Sacha J; Howell, Anthony; Hubbard, Gill; Hulbert-Williams, Nick; Hunter, Myra S; Jasani, Bharat; Jones, Louise J; Key, Timothy J; Kirwan, Cliona C; Kong, Anthony; Kunkler, Ian H; Langdon, Simon P; Leach, Martin O; Mann, David J; Marshall, John F; Martin, Lesley; Martin, Stewart G; Macdougall, Jennifer E; Miles, David W; Miller, William R; Morris, Joanna R; Moss, Sue M; Mullan, Paul; Natrajan, Rachel; O'Connor, James P B; O'Connor, Rosemary; Palmieri, Carlo; Pharoah, Paul D P; Rakha, Emad A; Reed, Elizabeth; Robinson, Simon P; Sahai, Erik; Saxton, John M; Schmid, Peter; Smalley, Matthew J; Speirs, Valerie; Stein, Robert; Stingl, John; Streuli, Charles H; Tutt, Andrew N J; Velikova, Galina; Walker, Rosemary A; Watson, Christine J; Williams, Kaye J; Young, Leonie S; Thompson, Alastair M

Transcript and protein profiling identifies signaling, growth arrest, apoptosis, and NF-κB survival signatures following GNRH receptor activation.

转录组和蛋白质组分析揭示了 GNRH 受体激活后的信号传导、生长停滞、细胞凋亡和 NF-κB 存活特征

Meyer Colette, Sims Andrew H, Morgan Kevin, Harrison Beth, Muir Morwenna, Bai Jianing, Faratian Dana, Millar Robert P, Langdon Simon P

A model of estrogen-related gene expression reveals non-linear effects in transcriptional response to tamoxifen

雌激素相关基因表达模型揭示了他莫昔芬对转录反应的非线性影响

Lebedeva, Galina; Yamaguchi, Azusa; Langdon, Simon P; Macleod, Kenneth; Harrison, David J

Data-independent proteomic screen identifies novel tamoxifen agonist that mediates drug resistance.

无需数据依赖的蛋白质组学筛选鉴定出一种介导耐药性的新型他莫昔芬激动剂

Hengel Shawna Mae, Murray Euan, Langdon Simon, Hayward Larry, O'Donoghue Jean, Panchaud Alexandre, Hupp Ted, Goodlett David R

Gonadotropin-releasing hormone analog structural determinants of selectivity for inhibition of cell growth: support for the concept of ligand-induced selective signaling

促性腺激素释放激素类似物抑制细胞生长选择性的结构决定因素:支持配体诱导选择性信号传导的概念

López de Maturana, Rakel; Pawson, Adam J; Lu, Zhi-Liang; Davidson, Lindsay; Maudsley, Stuart; Morgan, Kevin; Langdon, Simon P; Millar, Robert P